Targeted Glucose or Glutamine Metabolic Therapy Combined With PD-1/PD-L1 Checkpoint Blockade Immunotherapy for the Treatment of Tumors - Mechanisms and Strategies

Immunotherapy, especially PD-1/PD-L1 checkpoint blockade immunotherapy, has led tumor therapy into a new era. However, the vast majority of patients do not benefit from immunotherapy. One possible reason for this lack of response is that the association between tumors, immune cells and metabolic rep...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Oncol
Autori principali: Ma, Guofeng, Li, Chun, Zhang, Zhilei, Liang, Ye, Liang, Zhijuan, Chen, Yuanbin, Wang, Liping, Li, Dan, Zeng, Manqin, Shan, Wenhong, Niu, Haitao
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2021
Soggetti:
Oncology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8314994/
https://ncbi.nlm.nih.gov/pubmed/34327138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2021.697894
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi